CANTAM first African Network of Excellence for clini...( This release is available in a href...),Health

This release is available in French.

The countries of Central Africa have joined forces to enable the region to build research capacity and conduct clinical trials under best practices. CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria for the conduct of clinical trials) is the first EDCTP-funded regional Network of Excellence to prepare the region to conduct high-quality clinical trials. It will be supported by a EUR 3 million grant for the duration of three years. The network includes research institutions and political partners from Cameroon, Congo, Gabon, Tanzania and Germany. It is envisaged that the networks for Eastern, Western and Southern Africa will start their activities later this year.

The number of clinical trials on HIV/AIDS, tuberculosis and malaria conducted in Africa is increasing sharply and is expected to further increase in the coming years. The question is whether the countries of sub-Saharan Africa have sufficient clinical trials centres that are well equipped and staffed to ensure that these trials are conducted according to internationally acceptable standards.

EDCTP therefore set up a grant programme to fund regional Networks of Excellence, in which clinical trial centres from various African countries in Central, Eastern, Southern and Western Africa are interlinked at regional level, so that they can complement each other in building capacity to design and conduct large multi-centre clinical trials on HIV/AIDS, tuberculosis and malaria and other related diseases. Ultimately, the four networks will also work in collaboration and complement each other.

About CANTAM

The Central Africa Network on Tuberculosis, HIV/AIDS and Malaria for the Conduct of Clinical Trials (CANTAM) is the first network that will start on a regional level to develop capacities in the areas of good clinical
'/>"/>